These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

75 related articles for article (PubMed ID: 7500057)

  • 1. Prostate cancer screening.
    Lawrence G
    J Fam Pract; 1995 Dec; 41(6):536-7. PubMed ID: 7500057
    [No Abstract]   [Full Text] [Related]  

  • 2. The case for prostate cancer screening.
    Andriole GL
    Semin Urol; 1993 May; 11(2):50-3. PubMed ID: 7689738
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prostate cancer screening in the workplace. Employer costs.
    Snyder C; Schrammel PN; Griffiths CB; Griffiths RI
    AAOHN J; 1998 Aug; 46(8):379-84. PubMed ID: 9748918
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Community prostate cancer screening.
    Klamet A; Crighton F; Deisher R; Wingate A
    Cancer Pract; 1995; 3(6):366-71. PubMed ID: 15859167
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Role of free prostate-specific antigen measurement in prostate-specific antigen screening for prostate cancer.
    Johnson L
    Clin Prostate Cancer; 2002 Dec; 1(3):142-4. PubMed ID: 15046688
    [No Abstract]   [Full Text] [Related]  

  • 6. [Screening for prostatic cancer].
    Pushkar' DIu; Govorov AV; Bormotin AV
    Urologiia; 2003; (1):10-5. PubMed ID: 12621959
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prostate biopsy and optimization of cancer yield.
    Bostwick DG; Meiers I
    Eur Urol; 2006 Mar; 49(3):415-7. PubMed ID: 16442209
    [No Abstract]   [Full Text] [Related]  

  • 8. [Present-day possibilities of prostate cancer screening in patients with benign prostatic hyperplasia before and after surgical treatment].
    Pushkar' DIu; Rasner PI; Skobelev PP
    Urologiia; 2001; (6):48-54. PubMed ID: 11785083
    [No Abstract]   [Full Text] [Related]  

  • 9. [Early diagnosis by opportunistic screening in cancer of the prostate. Results of a 1-year protocol. Comparison with historical data].
    Gelabert Mas A; Arango Toro O; Carles Galcerán J; Bielsa Galí O; Cortadellas Angel R; Herrero Polo M; Griñó Garreta J; Foro Arnalot P; Nohales Taurines G; Carrasco Cánovas N
    Actas Urol Esp; 1997 Oct; 21(9):835-42. PubMed ID: 9471866
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Verification bias in screening for prostate cancer.
    Chatterton HT
    N Engl J Med; 2003 Oct; 349(17):1672-3; author reply 1672-3. PubMed ID: 14575055
    [No Abstract]   [Full Text] [Related]  

  • 11. First year of mass screening for prostatic cancer in Yaizu city.
    Kawabe K; Ishikawa A
    Aktuelle Urol; 2003 Jul; 34(4):242-3. PubMed ID: 14566673
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Screening for prostate cancer.
    Postma R; Schröder FH
    Eur J Cancer; 2005 Apr; 41(6):825-33. PubMed ID: 15808952
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Current and projected annual direct costs of screening asymptomatic men for prostate cancer using prostate-specific antigen.
    Krahn MD; Coombs A; Levy IG
    CMAJ; 1999 Jan; 160(1):49-57. PubMed ID: 9934343
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Ten year trend in prostate cancer screening with high prostate-specific antigen exposure rate in Japan.
    Okihara K; Kitamura K; Okada K; Mikami K; Ukimura O; Miki T
    Int J Urol; 2008 Feb; 15(2):156-60; discussion 161. PubMed ID: 18269453
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prostate screening.
    Conyngham B
    N Z Med J; 2004 Apr; 117(1192):U862. PubMed ID: 15107876
    [No Abstract]   [Full Text] [Related]  

  • 16. Screening for prostate cancer: a patient's view.
    N Z Med J; 2005 Apr; 118(1213):U1419. PubMed ID: 15843847
    [No Abstract]   [Full Text] [Related]  

  • 17. Re: Prospective evaluation of prostate cancer detected on biopsies 1, 2, 3 and 4: when should we stop?
    Ansari MS
    J Urol; 2002 Jul; 168(1):200; author reply 200-1. PubMed ID: 12050532
    [No Abstract]   [Full Text] [Related]  

  • 18. An evaluation of prostate-specific antigen as a screening test for prostate cancer.
    Dorr VJ; Williamson SK; Stephens RL
    Arch Intern Med; 1993 Nov; 153(22):2529-37. PubMed ID: 7694555
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Improving cancer detection by prostate biopsy: the role of core number and site.
    Shinohara K
    Nat Clin Pract Urol; 2006 Oct; 3(10):526-7. PubMed ID: 17031375
    [No Abstract]   [Full Text] [Related]  

  • 20. [Characteristics of screening-detected prostate cancer on health checkup].
    Uchida K; Akaza H
    Gan To Kagaku Ryoho; 1998 Aug; 25(10):1527-32. PubMed ID: 9725044
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.